HYPERION DEFI, INC. Preferred Stock, Value, Issued
HYPERION DEFI, INC. (HYPD) had Preferred Stock, Value, Issued of $524 as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:PreferredStockValue · last filed 2026-08-13
- 2026-06-30: Preferred Stock, Value, Issued $524.00.
- 2026-03-31: Preferred Stock, Value, Issued $524.00.
- 2025-12-31: Preferred Stock, Value, Issued $544.00.
- 2025-09-30: Preferred Stock, Value, Issued $544.00.
| Period end | Preferred Stock, Value, Issued |
|---|---|
| 2026-06-30 | $524.00 10-Q · filed 2026-08-13 |
| 2026-03-31 | $524.00 10-Q · filed 2026-05-15 |
| 2025-12-31 | $544.00 10-Q · filed 2026-08-13 |
| 2025-09-30 | $544.00 10-Q · filed 2025-11-14 |
| 2025-06-30 | $544.00 10-Q · filed 2025-08-13 |
| 2022-12-31 | $0.00 10-K · filed 2023-03-31 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-11 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-12 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-12 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-14 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-30 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-14 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-14 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-30 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-13 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-13 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-14 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |